Psychedelics get a hearing at FDA

The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.

This story was originally reported by NPR Health. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.